AI / ML Innovations Stock Price, News & Analysis

AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced its subsidiary, Tech2Heal SAS, is preparing to roll out its Alakin RPM platform in Q4 2021. The platform, designed for remote patient monitoring, will undergo initial pilot studies with major healthcare providers in Europe and South America. Alakin's SaaS model allows healthcare facilities to implement value-based care with minimal coding, featuring tools like telemedicine integration and configurable clinical protocols. The deployment aligns with value-based payment regulations in the US, Europe, and Brazil.

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) is preparing to launch its Alakin RPM platform in Q4 2021, developed by its subsidiary Tech2Heal SAS. This scalable SaaS solution focuses on remote patient monitoring and digital therapies, targeting healthcare providers in Europe and South America. Alakin includes features such as clinical protocol configurability, embedded telemedicine tools, and integrated patient records. The subscription model will be pivotal for providers, enhancing service delivery and aligning with value-based care regulations. This rollout could significantly impact AIMLF's market position.

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced a strategic partnership between its subsidiary Health Gauge and AI-on-Call to deliver a digital remote patient monitoring solution targeting sepsis and acute illnesses in seniors. The technology combines Health Gauge's smartwatch and cloud platform with AI-on-Call's protocols to enhance health data capture and patient outcomes. Initial deployments will occur in British Columbia, with a significant market opportunity across North America’s 60 million seniors. Pricing for the smartwatch is set at $200, with a subscription model starting at $5.00/month.

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announces significant advancements through its subsidiary Health Gauge, focusing on wearable health monitoring solutions. The company has established vital partnerships with organizations like BioAlberta, Edmonton Health City, and Digital Supercluster. These collaborations aim to enhance product development and expand market reach, promoting AI and ML innovation in healthcare. The partnerships are crucial for Health Gauge's strategy in addressing urgent health needs and transforming the digital healthcare landscape.

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced significant advancements through its subsidiary, Health Gauge. The company has established strategic relationships with key organizations such as BioAlberta, Edmonton Health City, the Digital Supercluster, and the Alberta Machine Intelligence Institute (amii). These collaborations aim to enhance Health Gauge's development of a wearable health monitoring solution, promoting innovation in digital healthcare.

Tim Daniels, Executive Chairman, emphasized the impact of these relationships on Health Gauge's market strategy and product development.

AI/ML Innovations Inc. (CSE: AIML, OTCQB: AIMLF) announced its participation in a live virtual presentation at VirtualInvestorConferences.com on August 5, 2021, at 11:30 AM ET. The event allows for real-time interaction between investors and the company, with an archived webcast available post-event. AI/ML Innovations focuses on acquiring AI and ML technologies, particularly in digital healthcare, having secured a 70% ownership in Health Gauge. Investors are encouraged to pre-register for the conference to enhance their experience.

AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) will present live at VirtualInvestorConferences.com on August 5th, 2021, at 11:30 AM EST. This interactive event will allow investors to engage with the company, asking questions in real-time. For those unable to attend, an archived version will be available. Investors are encouraged to pre-register and check their systems to ensure participation. AI/ML Innovations focuses on artificial intelligence and machine learning, particularly in digital healthcare.

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced the appointment of Mr. Nicholas Watters to its Board of Directors, effective July 16, 2021. Watters brings extensive corporate governance experience and has previously raised nearly $260 million for startups in various industries. AI/ML focuses on artificial intelligence and machine learning technologies, particularly in digital health. The company aims to enhance stakeholder value through strategic partnerships and investments.

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announced the resignation of John Cook from its Board of Directors due to health concerns. The company acknowledged his significant contributions and wished him a successful recovery. AI/ML is focused on leveraging artificial intelligence and machine learning within digital health initiatives, partnering with firms like Health Gauge and Tech2Health to improve healthcare management. The company aims to capitalize on growth opportunities in these sectors.